Featured Research

from universities, journals, and other organizations

Higher altitudes result in reduced concussion rates in high school sports

Date:
November 13, 2013
Source:
Cincinnati Children's Hospital Medical Center
Summary:
According to a recent study, high school athletes who play collision sports at higher altitudes are less likely to suffer from concussions than those who play at lower altitudes.

According to a recent study done by doctors at Cincinnati Children's Hospital Medical Center, high school athletes who play collision sports at higher altitudes are less likely to suffer from concussions than those who play at lower altitudes.

The doctors who were involved in the study recognized that prior research indicated that the volume and/or pressure of intracranial fluid, which acts as a cushion to protect the brain inside of the skull, is affected by one's altitude and that it may be associated with the likelihood and/or severity of a concussion. They hypothesized that when adjusting to higher altitudes, physiological responses increase intracranial fluid volume and these responses would provide a "tightened fit" which should help protect the brain from concussions like bubble wrap.

Data on concussions and more than 20 million athlete exposures were gathered between 2005 -2012 from nearly 500 high schools across the US. The data focused on concussion occurrence in a variety of sports including but not limited to boys' and girls' soccer, volleyball, basketball, cheerleading and boys' football and ice hockey. The altitude of the participating schools ranged from 7 to 6903 ft.

When concussion rates were examined relative to altitude, sequential elevations in altitude above sea level were associated with a reduction in concussion rates overall. Specifically, high school sports played at higher altitudes demonstrated a 31 percent reduction in the incidence of total reported concussions. Further analysis showed that concussion rates at increased altitude for football players were reduced by 30 percent for overall exposures, 27 percent for competition exposures and 28 percent for practice exposures.

Dr. Greg Myer, Director of Research, Sports Medicine, Cincinnati Children's Hospital Medical Center, says that "this research shows us that the physiological responses to altitude may be associated with a reduction in sports-related concussion rates, especially in collision sports."

He goes on to say that future research that focuses on other techniques that can optimize intracranial fluid volume (via jugular compression) will play an important role in the determination of the most effective approaches to prevent sport related concussion in athletes.


Story Source:

The above story is based on materials provided by Cincinnati Children's Hospital Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Cincinnati Children's Hospital Medical Center. "Higher altitudes result in reduced concussion rates in high school sports." ScienceDaily. ScienceDaily, 13 November 2013. <www.sciencedaily.com/releases/2013/11/131113125658.htm>.
Cincinnati Children's Hospital Medical Center. (2013, November 13). Higher altitudes result in reduced concussion rates in high school sports. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/11/131113125658.htm
Cincinnati Children's Hospital Medical Center. "Higher altitudes result in reduced concussion rates in high school sports." ScienceDaily. www.sciencedaily.com/releases/2013/11/131113125658.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins